Finished
DHACM in Robotic Assisted Laparoscopic Prostatectomy (RALP)
NCT02526173 · MiMedx Group, Inc. · Updated 28 Sept 2018
- What is being tested
- RALP using full nerve sparing technique; dHACM Application
- For
- Erectile Dysfunction
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 40 years to 70 years. About 230 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 1 Oct 2015, ends 21 June 2018. Registered 18 Aug 2015.
- Results
- None posted yet.
In the researchers' words
The investigators will examine the beneficial impacts of applying of dHACM on the preserved neurovascular bundles (cavernosal nerves) and the prostate bed during robotic assisted laparoscopic prostatectomy. Such application can result in promotion of soft tissue healing and reduction of inflammation at the operative site and thus an acceleration of return of potency regulating cavernosal nerves.
Sites
- Florida Hospital: Global Robotics InstituteCelebration, Florida, United States